Wells Fargo & Company MN Buys 9,566 Shares of Exactech, Inc. (EXAC)
Wells Fargo & Company MN boosted its stake in shares of Exactech, Inc. (NASDAQ:EXAC) by 14.2% during the third quarter, HoldingsChannel.com reports. The fund owned 76,907 shares of the medical equipment provider’s stock after acquiring an additional 9,566 shares during the period. Wells Fargo & Company MN’s holdings in Exactech were worth $2,534,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of EXAC. Hancock Holding Co. acquired a new stake in shares of Exactech in the 2nd quarter valued at $212,000. Citadel Advisors LLC acquired a new stake in shares of Exactech in the 2nd quarter valued at $235,000. Voya Investment Management LLC acquired a new stake in shares of Exactech in the 2nd quarter valued at $243,000. The Manufacturers Life Insurance Company boosted its holdings in shares of Exactech by 3.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock valued at $278,000 after purchasing an additional 289 shares in the last quarter. Finally, Prudential Financial Inc. acquired a new stake in shares of Exactech in the 2nd quarter valued at $359,000. Hedge funds and other institutional investors own 66.30% of the company’s stock.
Shares of Exactech, Inc. (NASDAQ:EXAC) opened at $50.50 on Friday. The firm has a market capitalization of $728.41, a price-to-earnings ratio of 41.74, a price-to-earnings-growth ratio of 3.73 and a beta of 1.02. Exactech, Inc. has a twelve month low of $23.30 and a twelve month high of $50.95. The company has a quick ratio of 2.09, a current ratio of 4.08 and a debt-to-equity ratio of 0.06.
EXAC has been the topic of a number of research analyst reports. Robert W. Baird downgraded Exactech from an “outperform” rating to a “neutral” rating and set a $42.00 target price on the stock. in a report on Monday, October 23rd. ValuEngine downgraded Exactech from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Sidoti downgraded Exactech from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. Zacks Investment Research raised Exactech from a “sell” rating to a “hold” rating in a report on Tuesday, December 26th. Finally, Gabelli downgraded Exactech from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Six equities research analysts have rated the stock with a hold rating, The stock currently has a consensus rating of “Hold” and a consensus price target of $49.00.
COPYRIGHT VIOLATION NOTICE: “Wells Fargo & Company MN Buys 9,566 Shares of Exactech, Inc. (EXAC)” was first posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/wells-fargo-company-mn-buys-9566-shares-of-exactech-inc-exac/1806835.html.
Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.
Want to see what other hedge funds are holding EXAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exactech, Inc. (NASDAQ:EXAC).
Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.